Company intelligence / Profile preview
Naturalendo Tech
- Ownership
- Private
- Development stage
- Other
Overview
Naturalendo Tech is a South Korean biotechnology company specializing in hormone-related health and advanced drug delivery systems. The company is best known for EstroG-100, a patented herbal extract used to alleviate menopausal symptoms, which has received regulatory approvals in multiple global markets including the US, Canada, and Europe. Beyond nutraceuticals, Naturalendo Tech develops innovative medical devices, specifically a biodegradable microneedle patch technology for transdermal drug delivery. Their research pipeline includes treatments for growth hormone deficiency and various dermatological applications.
- Therapeutic areas
- EndocrinologyDermatologyWomen's Health
- Modalities
- Herbal extractRecombinant proteinDevice
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Naturalendo Tech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Naturalendo Tech.